• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, April 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Media registration now open for 30th EORTC-NCI-AACR symposium

Bioengineer by Bioengineer
July 18, 2018
in Biology
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Journalists can now register online for the 30th EORTC-NCI-AACR symposium on "Molecular Targets and Cancer Therapeutics", which takes place in Dublin, Ireland, 13-16 November 2018.

The EORTC-NCI-AACR Symposium is unique in being THE scientific forum for developing cancer drugs for the future. Understanding the pathways and mechanisms that cause cancer and regulate the biological behaviour of tumour cells has led to the development of numerous new agents, 'designer' diagnostics, prognostic tests, 'smart' drugs, innovative targets for clinical trials and other entirely new ways of tackling cancer.

To bring these developments to patients as quickly and efficiently as possible requires international collaboration, early and optimal exchange of information, good quality translational research, efficient drug development and large prospective clinical trials.

At this Symposium, three of the world's leading cancer organisations:

  • The European Organisation for Research and Treatment of Cancer (EORTC)
  • The USA's National Cancer Institute (NCI)
  • The American Association for Cancer Research (AACR)

will join forces in Dublin on 13-16 November 2018 to provide a platform for presenting recent advances in pre-clinical and clinical research. Around 1,500 international experts in the field will be discussing innovations in drug development, target selection and the impact of new discoveries in molecular biology, while also promoting and developing global partnerships in translational research.

We welcome the media to the Symposium. Every session is open to journalists and registration is free to bona fide media presenting official press credentials, or a letter on headed paper from the editor of the journal/website they represent stating that they are being commissioned to write a report for publication. Copies of the credentials and identification will be requested at the time of registration and when journalists arrive at the Symposium. Business cards are NOT acceptable. A media centre with internet connections will be available. Full details can be found in the media policy (https://www.ecco-org.eu/Events/ENA2018/Media/Media-policy).

A media centre with internet connections will be available.

NB: the official language of the symposium is English and all press materials will be in English.

More information on the programme is available on the EORTC-NCI-AACR symposium website at: https://www.ecco-org.eu/Events/ENA2018

Accommodation:

Information on accommodation in Dublin can be found here: https://www.ecco-org.eu/Events/ENA2018/Travel

Reservations are made on a first-come, first-served basis and participants are advised to book early.

###

Media Contact

Emma Mason
[email protected]
@EuropeanCancer

http://www.ecco-org.eu

https://www.ecco-org.eu/Events/ENA2018

Share12Tweet8Share2ShareShareShare2

Related Posts

UBC Okanagan Study Reveals How Trees Visually Signal Their Spring Rehydration

UBC Okanagan Study Reveals How Trees Visually Signal Their Spring Rehydration

April 1, 2026
Rising Temperatures from Climate Change Associated with Reduced Newborn Size

Rising Temperatures from Climate Change Associated with Reduced Newborn Size

April 1, 2026

New Study Reveals Respiratory Evolution as Key Driver of Body Size Variation in Early Terrestrial Vertebrates

April 1, 2026

Survey Reveals Many Dog Owners Overlook Subtle Pain Signs Like Nighttime Restlessness and Clinginess

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1007 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Interpretable AI Boosts Cardiovascular Disease Diagnosis

Global Consensus on Active Surveillance for Low-Grade NMIBC

CUX2 Neuron Growth Demands Enhanced DNA Repair

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.